These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 26524350)
1. Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma. VandenBussche CJ; Rosenthal DL; Olson MT Cancer Cytopathol; 2016 Mar; 124(3):174-80. PubMed ID: 26524350 [TBL] [Abstract][Full Text] [Related]
2. Adequacy criteria for voided urine cytology using cytospin preparations. Renshaw AA; Gould EW Cancer Cytopathol; 2019 Feb; 127(2):116-119. PubMed ID: 30561909 [TBL] [Abstract][Full Text] [Related]
3. Determination of appropriate urine volume cutoff values for voided urine specimens to assess adequacy. Xing J; Qi Y; Monaco SE; Pantanowitz L J Am Soc Cytopathol; 2019; 8(2):89-94. PubMed ID: 31287425 [TBL] [Abstract][Full Text] [Related]
4. Adequacy of voided urine specimens prepared by ThinPrep and evaluated using The Paris System for Reporting Urinary Cytology. Rezaee N; Tabatabai ZL; Olson MT J Am Soc Cytopathol; 2017; 6(4):155-161. PubMed ID: 31043268 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of 'atypia' in instrumented versus voided urine specimens. Kapur U; Venkataraman G; Wojcik EM Cancer; 2008 Aug; 114(4):270-4. PubMed ID: 18548527 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of atypical urine cytology progression to malignancy. Muus Ubago J; Mehta V; Wojcik EM; Barkan GA Cancer Cytopathol; 2013 Jul; 121(7):387-91. PubMed ID: 23536358 [TBL] [Abstract][Full Text] [Related]
7. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive? Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL; Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938 [TBL] [Abstract][Full Text] [Related]
8. Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments. Onur I; Rosenthal DL; VandenBussche CJ Cancer Cytopathol; 2015 Mar; 123(3):186-92. PubMed ID: 25586692 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
11. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology. Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848 [TBL] [Abstract][Full Text] [Related]
12. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study. VandenBussche CJ; Sathiyamoorthy S; Owens CL; Burroughs FH; Rosenthal DL; Guan H Cancer Cytopathol; 2013 Jan; 121(1):21-8. PubMed ID: 23192913 [TBL] [Abstract][Full Text] [Related]
13. Adequacy of urine cytology specimens: an assessment of collection techniques. Hundley AF; Maygarden S; Wu JM; Visco AG; Connolly A Int Urogynecol J Pelvic Floor Dysfunct; 2007 Sep; 18(9):997-1001. PubMed ID: 17205220 [TBL] [Abstract][Full Text] [Related]
14. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type. Zhang ML; Rosenthal DL; VandenBussche CJ Cancer Cytopathol; 2016 Aug; 124(8):552-64. PubMed ID: 27019161 [TBL] [Abstract][Full Text] [Related]
15. Current status of urinary cytology in the evaluation of bladder neoplasms. Murphy WM Hum Pathol; 1990 Sep; 21(9):886-96. PubMed ID: 2203672 [TBL] [Abstract][Full Text] [Related]
16. Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma. Pierconti F; Martini M; Straccia P; Fiorentino V; Musarra T; Larocca LM; Lopez-Beltran A APMIS; 2018 Sep; 126(9):705-709. PubMed ID: 30160022 [TBL] [Abstract][Full Text] [Related]
17. When words matter: A "suspicious" urinary tract cytology diagnosis improves patient follow-up among nonurologists. Fite JJ; Rosenthal DL; VandenBussche CJ Cancer Cytopathol; 2018 Apr; 126(4):282-288. PubMed ID: 29360190 [TBL] [Abstract][Full Text] [Related]
18. Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer. Yafi FA; Brimo F; Auger M; Aprikian A; Tanguay S; Kassouf W Urol Oncol; 2014 Jan; 32(1):27.e1-6. PubMed ID: 23410943 [TBL] [Abstract][Full Text] [Related]
19. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Curry JL; Wojcik EM Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301 [TBL] [Abstract][Full Text] [Related]
20. Cytomorphological characteristics of low-grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high-grade papillary urothelial carcinoma. Takeda K; Adeniran AJ; Levi AW; Tang H; Cai G Cytopathology; 2024 Nov; 35(6):724-732. PubMed ID: 38992916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]